Rheumatology
ISSNs: 0263-7103, 1462-0324, 0300-3396, 0003-4908, 0365-5547
Additional searchable ISSN (electronic): 1462-0332, 1460-2172
Oxford University Press, United Kingdom
Scopus rating (2023): CiteScore 9.4 SJR 1.721 SNIP 1.544
Journal
1 - 10 out of 12Page size: 10
12 Research output
2024
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis
Distler, O., Ofner, C., Huscher, D., Jordan, S., Ulrich, S., Stähler, G. & Grünig, E. & 29 others, , 2 Apr 2024, In: Rheumatology. 63, 4, p. 1139-1146 8 p.Research output: Contribution to journal › Research article › Contributed › peer-review
PublishedEffects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease
SENSCIS Trial Investigators, Allanore, Y., Khanna, D., Smith, V., Aringer, M., Hoffmann-Vold, A. & Kuwana, M. & 4 others, , Mar 2024, In: Rheumatology. 63, 3, p. 639–647 9 p.Research output: Contribution to journal › Research article › Contributed › peer-review
PublishedP044 Janus Kinase Inhibitors-a retrospective study on side effects and discontinuation reasons
Klein, J., Alexander, J., Robertson, L. & Hollick, R., 2024, In: Rheumatology. 63, Suppl 1, keae163.086.Research output: Contribution to journal › Meeting abstract › Contributed
2023
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Kreuter, M., Bonella, F., Blank, N., Riemekasten, G., Müller-Ladner, U., Henes, J. & Siegert, E. & 20 others, , 1 Sept 2023, In: Rheumatology. 62, 9, p. 3067-3074 8 p.Research output: Contribution to journal › Research article › Contributed › peer-review
PublishedNovel mutation and expanding phenotype in IRF2BP2 deficiency
Körholz, J., Gabrielyan, A., Sczakiel, H. L., Schulze, L., Rejzek, M., Laass, M. W. & Leuchten, N. & 14 others, , Apr 2023, In: Rheumatology. 62, 4, p. 1699-1705 7 p.Research output: Contribution to journal › Case report › Contributed › peer-review
Published
2022
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension
JH, S., Spotswood, H., SH, U., Aringer, M., Blockmans, D., Brouwer, E. & MC, C. & 5 others, , 6 Jul 2022, In: Rheumatology. 61, 7, p. 2915–2922 8 p.Research output: Contribution to journal › Research article › Contributed › peer-review
PublishedGlucocorticoid dosing and relapses in giant cell arteritis-a single centre cohort study
Felten, L., Leuchten, N. & Aringer, M., May 2022, In: Rheumatology. 61, 5, p. 1997–2005 9 p.Research output: Contribution to journal › Research article › Contributed › peer-review
PublishedAnnular erythematous plaques as manifestation of vasculitis in pediatric Sjögren's syndrome
Appelt, L. M., Lander, F., Beissert, S. & Günther, C., Feb 2022, In: Rheumatology. 61, 2, p. E43-E45Research output: Contribution to journal › Research article › Contributed › peer-review
Published
2021
Interferon signature guiding therapeutic decision making: Ruxolitinib as first-line therapy for severe juvenile dermatomyositis?
Heinen, A., Schnabel, A., Brück, N., Smitka, M., Wolf, C., Lucas, N. & Dollinger, S. & 5 others, , Apr 2021, In: Rheumatology. 60, 4, p. E136-E138 3 p.Research output: Contribution to journal › Letter › Contributed › peer-review
Published
2020
Older age onset of systemic sclerosis - Accelerated disease progression in all disease subsets
German Network for Systemic Scleroderma & Günther, C., 24 Apr 2020, (E-pub ahead of print) In: Rheumatology. 59, 11, p. 3380-3389 10 p.Research output: Contribution to journal › Research article › Contributed › peer-review
E-pub ahead of print